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ABSTRACT 
Background: High-volume hospitals have been associated with improved patient outcomes for tumors with a 
relatively low incidence that require complex surgeries, such as esophageal and pancreatic cancer. The volume-
outcome association for colorectal cancer is under debate.  
Objective: This study investigated whether hospital volume for colorectal cancer is associated with surgical care 
characteristics and 5-year overall survival. 
Design: This is a population-based study. 
Setting: Data were gathered from the Netherlands Cancer Registry. Hospitals were grouped by volume for colon 
(less than 50; 50-74; 75-99 and 100 or more resections per year) and rectum (less than 20; 20-39 and 40 or more 
resections per year). 
Patients: All of the patients with primary nonmetastatic colorectal cancer who underwent resection between 
2005 and 2012 were included. 
Main outcome measures: Differences in surgical approach, anastomotic leakage, and postoperative 30-day 
mortality between hospital volumes were analysed using χ2 tests and multivariable logistic regression analyses. 
Cox proportional hazard models were used to investigate the effect of hospital volume on overall survival. 
Results: This study included 61,394 patients with colorectal cancer. In 2012, 31 of the 91 hospitals performed 
less than 50 colon cancer resections per year and 21 of the 90 hospitals performed less than 20 rectal cancer 
resections per year. No differences in anastomotic leakage between hospital volumes were observed. Only small 
differences between hospital volumes were revealed for conversion of laparoscopic to open resection (OR of less 
than 50 versus 100 or more resections per year = 1.25 (95% CI, 1.06-1.46) and postoperative 30-day mortality 
(colon: OR of less than 50 versus 100 or more resections per year = 1.17 (95% CI, 1.02-1.35); rectum: OR of 
less than 20 versus 40 or more resections per year = 1.42 (95% CI, 1.09-1.84)). No differences in overall survival 
were found between hospital volumes.  
Limitations: Although we adjusted for several patient and tumor characteristics, data regarding comorbidity, 
surgeon volume, local recurrences, and specific postoperative complications other than anastomotic leakage 
were not available. 
Conclusion: In the Netherlands, no differences in 5-year survival rates were revealed between hospital volumes 
for patients with nonmetastatic colorectal cancer. 
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INTRODUCTION 
In the last decade, there has been an increasing interest in improving quality of cancer care and the need for 
reliable parameters thereof. Differences in hospital volume and its relation with patient outcomes have been 
studied extensively in the ongoing debate of centralization of surgical care.1-3 In tumors with a relatively low 
incidence that require complex surgeries, such as oesophageal and pancreatic cancer, patients have better short- 
and long-term outcomes when operated in high-volume hospitals.4-9  
In 2011 the Dutch Society for Surgery established a minimum volume norm of 50 colorectal cancer (CRC) 
resections per year per hospital. Additionally, for rectal cancer a minimum volume norm of 20 resections per 
year per hospital is required.10 For patients with CRC, the volume-outcome association is under debate.  
A Cochrane review from 2012 showed that 5-year overall survival (OS) was higher for patients with CRC who 
were treated in high-volume hospitals. For only patients with patients with rectal cancer, 5-year OS rate but not 
postoperative mortality was higher in high-volume hospitals. The quality of the evidence was regarded as low in 
this review, and evidence was based on studies with a large heterogeneity in volume definitions.11  
Because it is still not clear to what extent hospital volume differences between hospitals lead to differences in 
short- and long-term patient outcomes, we aimed to investigate whether hospital volume determines surgical care 
characteristics, postoperative 30-day mortality rates, and long-term survival in patients with CRC in the 
Netherlands. On the basis of previous literature, we hypothesized that high-volume hospitals are not associated 
with better OS rates. Furthermore, we hypothesize that there was no association between surgical care 
characteristics (eg,. presence of anastomotic leakage and postoperative 30-day mortality) and hospital volumes. 
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METHODS 
 
Data source 
Data from the nationwide population-based Netherlands Cancer Registry were used, managed by the 
Netherlands Comprehensive Cancer Organisation. Information on patient and tumor characteristics, diagnosis, 
and treatment is routinely extracted from the medical charts. The quality of the data is high because of thorough 
training of the registration team and computerized consistency checks at regional and national levels. Anatomical 
site of the tumor is registered according to the International Classification of Disease–Oncology.12 The TNM 
classification is used for stage notification of the primary tumor, according to the edition valid at time of cancer 
diagnosis.13  
 
Study population 
All patients who underwent surgical resection for primary stage I to III CRC (C18-20) between 2005 and 2012 
were included. Data for the evaluation of surgical care (eg, surgical approach, emergency resection, and 
anastomotic leakage) were available in the Netherland Cancer Registry since 2008; therefore, we limited our 
selection for these analyses to patients who underwent surgical resection in 2009-2012. Patients who underwent 
surgical resection without primary anastomosis were excluded from the analyses regarding anastomotic leakage 
(n=2981). 
Disease stage was based on the pathological TNM classification. Patients were stratified by tumor localization: 
colon (C18) and rectum (rectosigmoid and rectum, C19-20). Tumor localization was categorized into anatomical 
subsites: proximal colon (C18.0-18.3), transverse colon and splenic flexure (C18.4-18.5), distal colon (C18.6-
1.87), unknown or overlapping subsites of the colon (C18.8-18.9); rectosigmoid (C19.9), and rectum (C20.9).  
Surgical care characteristics were recorded for the following categories: surgical approach (laparoscopic 
resection versus intent for laparoscopic but conversion to open resection versus open resection); presence of an 
anastomotic leakage, and postoperative 30-day mortality. Anastomotic leakage was only recorded as such if a 
surgical intervention or readmission was necessary within two months after primary anastomosis. 
Patient vital status was obtained by linking the Netherlands Cancer Registry to the Municipal Personal Records 
Database. Follow-up was completed until January 1, 2015.  
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Hospital volumes 
After stratification by tumor localization, the number of resections per year per hospital over the period 2005-
2012 were calculated. Hospitals were divided per year into separate categories for colon and rectal cancer based 
on their annual hospital volume. Hospital volume for colon cancer was divided into 4 categories: less than 50; 
50-74; 75-99 and 100 or more resections per year. Hospital volume for rectal cancer was divided into 3 
categories: less than 20; 20-39 and 40 or more resections per year. The lowest category for colon cancer was 
based on the Dutch minimum volume norm for CRC because there were no minimum requirements available for 
colon cancer separately. The lowest category for rectal cancer was based on the Dutch minimum volume norm 
for rectal cancer. The higher categories for both colon and rectal cancer were chosen to create an equal 
distribution of patients between hospital volume categories. 
All of the hospitals in the Netherlands were included. Hospitals that merged in the period 2005-2012 were 
counted as separate until the date of the merge and as 1 after the merge or the subsequent year if this was during 
the year. 
 
Statistical analyses 
Differences in patient and tumor characteristics, observed proportions of anastomotic leakage, and postoperative 
30-day mortality between hospital volumes were calculated using χ2 tests after stratification by tumor 
localization. In addition, for patients with a tumor located in the colon, differences in surgical approach between 
hospital volumes were analyzed using the same methods. Multivariable logistic regression models were used to 
determine adjusted ORs for surgical approach, presence of anastomotic leakage, and postoperative 30-day 
mortality adjusting for sex, age, T stage, N stage, differentiation grade, tumor location, and neoadjuvant 
treatment (the latter for rectal cancer only). 
Crude 1-, 3- and 5-year OS were calculated using the Kaplan-Meier method, and differences in OS outcomes 
were assessed with the log-rank test. OS was also determined using Cox proportional hazard models. Patients 
who survived the first 30 days after the date of resection were included in the survival analyses. Follow-up time 
was defined as the time between 30 days after resection and either date of death or last follow-up date for 
patients who were still alive. Patient and tumor characteristics influencing survival were included as covariates 
in the model to discriminate independent risk factors for death.  
P values <0.05 were considered statistically significant. SAS/STAT® statistical software (SAS system 9.4, SAS 
Institute, Cary, NC) was used for all analyses. 
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RESULTS 
Over the period 2005-2012, 61,496 patients underwent surgical resection for primary nonmetastatic CRC: 
41,015 patients with colon cancer and 20,481 patients with rectal cancer. Table 1 presents the number of 
hospitals per hospital volume per year, showing a decreasing trend in low-volume hospitals. Fig. 1 shows the 
annual average hospital volume, per hospital, in the period 2005-2012, combined with  the annual minimum and 
maximum (range) hospital volume, per hospital, for colon and rectal cancer. 
Table 2 shows the distribution of patient and tumor characteristics of the patients who underwent surgical 
resection for CRC by hospital volume and tumor localization. Statistically significant differences were found 
between hospital volumes for colon and rectal cancers with regard to age, period of resection, T stage, N stage, 
and differentiation grade. 
 
Surgical approach in patients with colon cancer 
Table 3 presents observed proportions and adjusted ORs of laparoscopic resection by hospital volume. The 
distribution of surgical approaches differed between hospital volumes (p<0.0001). Moreover, among patients 
initially treated laparoscopically, a higher proportion of patients underwent conversion from laparoscopic to 
open resection in low-volume hospitals compared with high-volume hospitals (p=0.011; Table 3). 
 
Anastomotic leakage 
Table 3 presents observed proportions and adjusted ORs of anastomotic leakage by hospital volume and tumor 
localization. For patients with either colon or rectal cancer, no differences were found between hospital volumes 
(colon p=0.81; rectum p=0.97).  
 
Postoperative mortality 
Table 3 presents observed proportions and adjusted ORs for postoperative 30-day mortality by hospital volume 
and tumor localization. For both colon and rectal cancers, postoperative mortality was marginally higher in low-
volume hospitals (colon p=0.029; rectum p=0.007).  
 
Survival 
Median follow-up time for patients included was 60 months. For patients with colon cancer, crude 1-, 3-, and 5-
year observed survival rates were similar between hospital volumes, at 94%, 81% and 71% (p=0.49; Fig. 2a). 
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For patients with rectal cancer, crude 1-, 3-, and 5-year observed survival rates were also similar between 
hospital volumes, at 96%, 84% and 74% (p=0.71; Fig. 2b). 
Table 4 shows adjusted HRs for death by hospital volume. The risk of death was not correlated with hospital 
volume for patients with either colon or rectal cancer. 
When the analyses were repeated with the hospitals that performed less than 50 colon resections per year or less 
than 20 rectum resections per year versus hospitals that performed 50 or more colon resections per year or 20 or 
more rectum resections per year, similar results were found for OS (data not shown). 
 
Subgroup analyses excluding patients who underwent emergency resection 
As a sensitivity analysis, all analyses were repeated for the period 2009-2012 excluding patients who underwent 
emergency resection. Similar results were found for surgical approach, presence of anastomotic leakage, 
postoperative 30-day mortality rate, and OS (data not shown). 
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DISCUSSION 
In this population-based study covering the Netherlands in the period 2005-2012, we analyzed to what extent 
hospital volumes lead to differences in short- and long-term patient outcomes. We found no differences in OS 
between hospitals that did and did not meet the Dutch minimum volume norms for CRC. However, marginal 
differences were found between hospital volumes in surgical approach and postoperative 30-day mortality rates. 
Our data were based on all consecutive nonmetastatic CRC patients who underwent resection in the Netherlands 
between 2005 and 2012. Conflicting evidence exists as to whether hospital volume is associated with differences 
in postoperative mortality and OS in CRC. The variation in results between studies may be caused by the 
hospital volume categories that are differently defined in the literature. The cutoff for low volume ranged from 
25 or less to 90 or less CRC resections, and the number of CRC resections considered as high volume ranged 
from 25 or more to 110 or more.11 Furthermore, the low-volume thresholds used in this study would place Dutch 
hospitals in high-volume categories in most studies originating from the United States.1, 14, 15 Other studies 
categorized hospitals based on the CRC hospital volume16, 17, whereas we intentionally separated colon and 
rectal cancers because of differences in surgical procedures. A subgroup analysis in a meta-analysis of the 
Cochrane collaboration, where studies were grouped according to continent of origin, showed that studies 
originating from other countries than the United States had no significant hospital volume effect on 5-year 
survival, whereas US data suggested a potential benefit for high-volume hospitals.11 Similar to the results found 
in non-US studies, we demonstrated no better survival in high-volume hospitals. Moreover, patient selection 
varied between studies, some only included patients aged >65 years with CRC.18, 19 Furthermore, we excluded 
patients with metastatic disease while others have included these.19-23  
For patients with colon cancer who were initially treated laparoscopically, we found a slightly higher proportion 
of patients (4%) converted from laparoscopic to open resection in hospitals with less than 50 resections per year 
compared with hospitals with 100 or more resections per year. van Erning et al24 showed a similar trend in a 
population-based study in the southern part of the Netherlands. Laparoscopic resection is proven to be safe, with 
comparable disease-free and OS compared with open resection.25, 26 However, conversion to open resection is 
associated with increased morbidity, longer length of hospital stay, and shorter disease-free survival.27-29 The 
technique of laparoscopic resection is still in progress, hence it is likely that variance in proportions of 
laparoscopic resection between hospitals will decrease.  
Interestingly, marginal differences in postoperative mortality rates were present between hospital volumes for 
patients with colon or rectal cancer. For patients with rectal cancer, this was in line with a previous Dutch study 
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of Elferink et al.30 In this study, patients who were operated in hospitals with 50 or more resections per year had 
lower odds of dying within 30 days compared with patients who were operated in hospitals with less than 25 
resections per year. When these results are compared with our results, it seems that the postoperative mortality 
rates have not been changed over time. More studies found an association between postoperative mortality and 
hospital volumes.1, 14, 21-23, 31, 32 A possible explanation could be that a higher standard of care is provided in high-
volume hospitals by more specialized and experienced surgeons and by more technically advanced equipment. 
Another possible explanation could be that low-volume hospitals with higher postoperative mortality rates are 
less skilled to recognize and manage serious complications once they occur, a phenomenon known as failure to 
rescue.33 Nevertheless, Henneman et al34 showed recently that annual average hospital volume was not 
significantly associated with failure to rescue in the Netherlands. We found no associations between hospital 
volumes and the presence of anastomotic leakage, even though lower rates of postoperative complications in 
high-volume hospitals were expected. Data on other specific postoperative complications were not available. 
Finally, elderly patients and patients with comorbidities were reported to be associated with higher risk of 
postoperative mortality, but this was not associated with hospital volume.24    
The main strengths of this study are the use of a large dataset including more than 60,000 CRC patients and the 
inclusion of all hospitals in the Netherlands. Furthermore, the lowest-volume categories in our study were based 
on the Dutch minimum volume norms. We calculated the annual hospital volume according to tumor location, 
instead of calculating an average over the included years.  
Due to the increasing incidence of CRC,35 hospital volumes became substantially higher through the years. 
Moreover, during the study period some hospitals have merged, thereby increasing their annual hospital volume. 
In anticipation of the mergers, hospitals may have collaborated and made agreements about referral of patients 
who needed complex surgeries. This could have led to a higher number of complex patients treated in certain 
hospitals, which may have led to a worse outcome in these hospitals. Although the number of referred patients 
may be small and one might expect to see a minor effect,  we have adjusted for several patient and tumor 
characteristics in our analyses.  
However, some shortcomings of our study should be noted. We could not adjust for hospital volume of local 
recurrences (mainly for rectal cancer), which are mostly treated in a limited number of hospitals, thereby 
underestimating the volume of these hospitals. Moreover, a recent Dutch study by Homan et al36 suggested a 
trend toward a higher involved circumferential resection margin of 13% in patients with rectal cancer at low-
volume hospitals (less than 20 per year) versus 6% in high-volume hospitals (more than 40 per year) in a small 
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area of The Netherlands. However, data on completeness of the surgical resection, as well as data regarding local 
recurrence, were not routinely available in the nationwide cancer registry. Furthermore, we cannot exclude that 
other factors, such as variation in comorbidities between patients treated in different hospitals, may have 
influenced our results as well. Moreover, we studied the number of resections on the hospital level and not on the 
surgeon level. Several studies showed that postoperative mortality was lower for surgeons with a higher caseload 
of patients with colon cancer, regardless of the hospital volume of the hospital in which the surgeons practiced.15, 
22, 31, 37-39 This suggests that an association between hospital volumes and postoperative mortality could be 
mediated by surgeon volume. Unfortunately, data on surgeon volume were not available. 
Because of the large data set, one might dispute whether the statistically significant differences that were present 
between hospital volumes are clinically relevant. For example, the difference in postoperative mortality rates 
between lowest- and highest-volume hospitals was ≈1%. Future studies should focus on the identification of 
processes associated with good outcomes and factors causing variation between individual hospitals. However, 
identification of these processes and their effect on quality of care remains challenging.  
No differences in 5-year OS rates were revealed between hospital volumes for patients with nonmetastatic CRC. 
However, marginal differences in surgical approach and postoperative 30-day mortality rates were present 
between hospital volumes. Exploring factors causing variation between hospitals will provide more insight in the 
quality-of-care debate on whether undergoing a resection in a low-volume hospital is a risk factor for 
unfavorable patient outcomes. 
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Table 1 Total number of hospitals per annual hospital volume of colon and rectal cancers in 2005-2012 n=(61,496). 
 
Hospital volume per year 2005 2006 2007 2008 2009 2010 2011 2012 
 
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Colon cancer 
        <50 65 (68) 54 (57) 54 (57) 47 (50) 46 (50) 37 (41) 35 (38) 31 (34)
50-74 18 (19) 29 (31) 25 (27) 31 (33) 22 (24) 27 (30) 22 (24) 26 (29) 
75-99 10 (11) 10 (11) 13 (14) 12 (13) 18 (20) 14 (15) 17 (19) 15 (16) 
≥100 2 (2) 1 (1) 2 (2) 4 (4) 6 (6) 13 (14) 17 (19) 19 (21) 
         Total hospitals performing colon cancer resections, n 95 94 94 94 92 91 91 91
         Rectal cancer 
        <20 43 (45) 38 (40) 32 (34) 35 (38) 29 (32) 28 (31) 24 (27) 21 (23)
20-39 37 (39) 38 (40) 44 (47) 43 (47) 47 (51) 45 (49) 44 (49) 46 (51) 
≥40 15 (16) 18 (20) 18 (19) 14 (15) 16 (17) 18 (20) 22 (24) 23 (26) 
         Total hospitals performing rectal cancer resections, n 95 94 94 92 92 91 90 90
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Table 2 Patient and tumour characteristics of patients who underwent surgical resection for colon or rectal cancer (n=61496). 
  Hospital volume 
 
Colon 
  
Rectum 
  Variable <50 per y 50-74 per y 75-99 per y ≥100 per y   p <20 per y 20-39 per y ≥40 per y   p 
  n (%) n (%) n (%) n (%)     n (%) n (%) n (%)     
Total 8279 (20) 11645 (29) 8663 (21) 12428 (30) 
  
2545 (13) 8830 (43) 9106 (44) 
  
            Sex 
     
0.59 
    
0.73 
   Men 4269 (51) 5908 (51) 4403 (51) 6296 (51)
  
1525 (60) 5366 (61) 5503 (60)
     Women 4010 (49) 5737 (49) 4260 (49) 6132 (49) 
  
1020 (40) 3464 (39) 3603 (40) 
  Age, y 
     
0.001* 
    
0.027* 
   <60 1425 (17) 1937 (17) 1399 (16) 1895 (15)
  
627 (24) 2148 (14) 2174 (24)
     60-69  2213 (27) 3076 (26) 2215 (26) 3283 (26) 
  
781 (31) 2764 (32) 2991 (32) 
     70-79  2750 (33) 4029 (35) 2975 (34) 4416 (36) 
  
757 (30) 2734 (31) 2788 (31) 
     ≥80  1891 (23) 2603 (22) 2074 (24) 2834 (23) 
  
380 (15) 1184 (13) 1153 (13) 
  Period of resection 
     
<0.0001* 
    
<0.0001* 
   2005-2006 2674 (33) 2723 (23) 1934 (23) 1248 (10)
  
782 (31) 2072 (23) 1772 (20)
     2007-2008 2204 (26) 3171 (27) 1993 (23) 2133 (17) 
  
626 (25) 2245 (25) 2176 (24) 
     2009-2010 1942 (23) 2835 (25) 2340 (26) 3656 (30) 
  
611 (24) 2295 (27) 2252 (24) 
     2011-2012 1459 (18) 2916 (25) 2396 (28) 5391 (43) 
  
526 (20) 2218 (25) 2906 (32) 
  T stage 
     
0.010* 
    
0.0001* 
   1 598 (  7) 873 (  8) 601 (  7) 903 (  7)
  
241 (  9) 886 (10) 1067 (12)
     2 1329 (16) 1864 (16) 1377 (16) 1907 (15) 
  
872 (34) 2939 (34) 2935 (32) 
     3 5192 (63) 7257 (62) 5604 (65) 7929 (64) 
  
1332 (52) 4553 (51) 4623 (51) 
     4 1160 (14) 1651 (16) 1081 (12) 1689 (14) 
  
100 (  4) 452 (  5) 481 (  5) 
  N stage 
     
0.018* 
    
0.045* 
   0 5206 (63) 7471 (64) 5681 (65) 7896 (64)
  
1649 (65)  5896 (67) 6184 (68)
     1 2012 (24) 2789 (24) 2018 (23) 3093 (25) 
  
603 (24) 1955 (22) 1972 (22) 
     2 1061 (13) 1385 (12) 1027 (12) 1439 (11) 
  
293 (11) 979 (11) 950 (10) 
  Differentiation grade 
    
<0.0001* 
        Well/moderated 6218 (75) 8699 (75) 6574 (76) 9310 (75)
          Poor/undifferentiated 1235 (15) 1932 (16) 1376 (16) 1902 (15) 
          Unknown 826 (10) 1014 (  9) 713 (  8) 1216 (10) 
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Table 2  continued            
  Hospital volume 
 Colon   Rectum   
Variable <50/yr 50-74/yr 75-99/yr ≥100/yr   p-value <20/yr 20-39/yr ≥40/yr   p-value 
  n (%) n (%) n (%) n (%)     n (%) n (%) n (%)     
Tumor location 
     
0.79 
    
<0.0001* 
   Colon ascendens 3187 (38) 4401 (38) 3284 (38) 4819 (39)
          Colon transversum 1513 (18) 2162 (18) 1599 (18) 2200 (17) 
          Colon descendens 3446 (42) 4878 (42) 3633 (42) 5197 (42) 
          Colon NOS/other 133 (  2) 204 (  2) 147 (  2) 212 (  2) 
          Rectosigmoid 
      
405 (16) 1270 (14) 1101 (12)
     Rectum 
      
2140 (84) 7560 (86) 8005 (88) 
  NOS =  not otherwise specified. 
* p<0.05 between hospital volume categories. 
 
 
 
Table 3 Crude percentages and adjusted ORs for laparoscopic resection and conversion from laparoscopic to 
open resection among patients with colon cancer, as well as anastomotic leakage and postoperative 30-day 
mortality among patients with colon or rectal cancer. 
 
      Multivariable analysis 
 Variable Crude % p OR 95% CI 
Laparoscopic resection b 
Colon cancer, per y  <0.001a   
   <50 42.2  1.04 0.96-1.13 
    50-74 43.4  1.10 1.03-1.18 
   75-99 38.2  0.88 0.82-0.95 
   ≥100 40.8  reference  
Conversion from laparoscopic  to open resection c 
Colon cancer, per y  0.020a   
   <50 20.2  1.25 1.06-1.46 
    50-74 19.4  1.20 1.05-1.37 
   75-99 18.5  1.14 0.98-1.33 
   ≥100 16.9  reference  
Anastomotic leakage d 
Colon cancer, per y  0.81   
   <50 8.2  0.95 0.81-1.10 
    50-74 8.4  0.99 0.88-1.13 
   75-99 8.4  0.97 0.85-1.11 
   ≥100 8.6  reference  
Rectal cancer, per y  0.97   
   <20 13.2  1.03 0.79-1.34 
   20-39 13.2  0.97 0.83-1.15 
   ≥40 13.4  reference  
                   Postoperative mortality e 
Colon cancer, per y  0.029 a    
   <50 4.4  1.17 1.02-1.35 
    50-74 4.7  1.24 1.09-1.41 
   75-99 4.3  1.10 0.96-1.27 
   ≥100 3.9  reference  
Rectal cancer, per y  0.007 a    
   <20 3.4  1.42 1.09-1.84 
   20-39 2.6  1.12 0.92-1.36 
   ≥40 2.3   reference   
ORs were adjusted for sex, age, year of surgical resection, T stage, N stage, differentiation grade, tumor location, 
and neoadjuvant treatment (the latter for rectal cancer only). 
ap<0.05. 
bData include patients diagnosed between 2009 and 2012 (N=20,589). 
cData include patients diagnosed between 2009 and 2012 who underwent laparoscopic resection (N=9162). 
dData include patients diagnosed between 2009 and 2012 who underwent surgical resection with primary 
anastomosis (N=26,871). 
eData include patients diagnosed between 2005 and 2012 (N=61,496). 
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Table 4 Cox regression analysis for the relation of the number of patients who underwent surgical resection for 
colon or rectal cancer per hospital per year and the risk of death of patients with colon and rectal cancer in the 
Netherlands, 2005-2012 (n=58,218). 
 
Adjusted 
 Hospital volume HRa 95% CI 
Colon cancer, per y 
     <50 1.03 0.97-1.08 
    50-74 1.02 0.97-1.06 
   75-99 0.99 0.94-1.04 
   ≥100 reference 
    Rectal cancer, per y 
     <20 0.98 0.91-1.07 
   20-39 1.00 0.95-1.06 
   ≥40 reference 
 a HR was adjusted for sex, age, year of surgical resection, T stage,  
N stage, differentiation grade, and tumour location. 
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a. 
 
 
b. 
 
Figure 1. The annual average hospital volume, per hospital, in the period 2005-2012, combined with the annual 
minimum and maximum (range) hospital volume, per hospital, for colon cancer (a) and rectal cancer (b) 
(n=58,218). 
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Figure 2. Crude overall survival of patients with colon (a) and rectal (b) cancer according to hospital volume 
categories in the Netherlands, 2005-2012 (n=58,218). 
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